Previous close | 62.13 |
Open | 61.40 |
Bid | 60.95 x 50000 |
Ask | 61.02 x 50000 |
Day's range | 61.40 - 61.65 |
52-week range | 60.00 - 80.08 |
Volume | |
Avg. volume | 515 |
Market cap | 76.876B |
Beta (5Y monthly) | 0.20 |
PE ratio (TTM) | 186.82 |
EPS (TTM) | 0.33 |
Earnings date | 25 Apr 2024 |
Forward dividend & yield | 2.88 (4.67%) |
Ex-dividend date | 14 Jun 2024 |
1y target est | N/A |
FOSTER CITY, Calif., April 30, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript April 25, 2024 Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.49. Gilead Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone, and […]
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.